Literature DB >> 33744668

Association of skin infections with sharing of injection drug preparation equipment among people who inject drugs.

Raagini Jawa1, Michael D Stein2, Bradley Anderson3, Jane M Liebschutz4, Catherine Stewart5, Kristina T Phillips6, Joshua A Barocas7.   

Abstract

BACKGROUND: Sharing needles and injection drug preparation equipment (IDPE) among people who inject drugs (PWID) are well-established risk factors for viral transmission. Shared needles and IDPE may serve as bacterial niduses for skin and soft tissue infections (SSTI). Given the rising rates of SSTI in PWID, we investigated the association of needle and IDPE sharing on incidence of SSTI in a cohort of PWID.
METHODS: Inpatient PWID (N = 252) were recruited to a randomized controlled trial of an intervention aimed at reducing infections. The primary outcome was self-reported incidence of SSTI one-year post-hospitalization. In this secondary analysis, we assessed two variables: 1) sharing of IDPE alone, 2) sharing needles with or without IDPE, and compared these groups separately to persons who reported no sharing of needles or IDPE via a mixed-effects negative binomial regression model to estimate the effect of baseline sharing behavior on SSTI during follow-up via incidence rate ratios (IRR).
RESULTS: Participant characteristics: 38 years [mean], 58% male, 60% White, 90% primarily injected opioids, 1.58 (± 2.35) mean SSTI in the year prior to baseline. In terms of sharing behavior, 29% didn't share needles or IDPE, 13% shared IDPE only, and 58% shared needles with or without IDPE three months prior to baseline. After adjusting for co-variables, PWID who shared IDPE alone had a 2.2 fold higher IRR of SSTI (95%CI 1.27; 3.85, p = 0.005) and PWID who shared needles with or without IDPE had a 3.31 fold higher IRR of SSTI (95%CI 2.04; 5.37, p < 0.001), compared to those who did not share any equipment. The number of SSTI at baseline was associated with an IRR of 1.20 of SSTI during follow-up (95%CI 1.09; 1.32, p < 0.001).
CONCLUSIONS: In this cohort of hospitalized PWID, we found a significant association between baseline sharing of IDPE alone and of sharing of needles with or without IDPE with one-year incidence of SSTI.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bacterial infections; Harm reduction; Injection drug use; Injection equipment; Skin infection

Mesh:

Substances:

Year:  2021        PMID: 33744668      PMCID: PMC8373634          DOI: 10.1016/j.drugpo.2021.103198

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  66 in total

1.  Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial.

Authors:  D C Des Jarlais; D Paone; J Milliken; C F Turner; H Miller; J Gribble; Q Shi; H Hagan; S R Friedman
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

2.  Prevalence and correlates of prescription opioid residue injection.

Authors:  Élise Roy; Nelson Arruda; Karine Bertrand; Magali Dufour; Émélie Laverdière; Didier Jutras-Aswad; Michel Perreault; Djamal Berbiche; Julie Bruneau
Journal:  Drug Alcohol Depend       Date:  2016-06-29       Impact factor: 4.492

3.  Safer injection facility use and syringe sharing in injection drug users.

Authors:  Thomas Kerr; Mark Tyndall; Kathy Li; Julio Montaner; Evan Wood
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

4.  Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors.

Authors:  L Greenfield; G E Bigelow; R K Brooner
Journal:  Drug Alcohol Depend       Date:  1995-08       Impact factor: 4.492

5.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

Review 6.  The role of safer injection facilities in the response to HIV/AIDS among injection drug users.

Authors:  Thomas Kerr; Jo Kimber; Kora Debeck; Evan Wood
Journal:  Curr HIV/AIDS Rep       Date:  2007-12       Impact factor: 5.071

7.  Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England.

Authors:  Vivian Hope; Jo Kimber; Peter Vickerman; Matthew Hickman; Fortune Ncube
Journal:  BMC Infect Dis       Date:  2008-09-18       Impact factor: 3.090

8.  Heating Injection Drug Preparation Equipment Used for Opioid Injection May Reduce HIV Transmission Associated With Sharing Equipment.

Authors:  Laura J Ball; Colin Venner; Rommel G Tirona; Eric Arts; Kaveri Gupta; Joshua C Wiener; Sharon Koivu; Michael S Silverman
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-01       Impact factor: 3.731

9.  Sharing of Injection Drug Preparation Equipment Is Associated With HIV Infection: A Cross-sectional Study.

Authors:  Laura J Ball; Klajdi Puka; Mark Speechley; Ryan Wong; Brian Hallam; Joshua C Wiener; Sharon Koivu; Michael S Silverman
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-01       Impact factor: 3.731

10.  Skin-cleaning among hospitalized people who inject drugs: a randomized controlled trial.

Authors:  Michael D Stein; Kristina T Phillips; Debra S Herman; Julia Keosaian; Catherine Stewart; Bradley J Anderson; Zoe Weinstein; Jane Liebschutz
Journal:  Addiction       Date:  2020-09-21       Impact factor: 6.526

View more
  1 in total

1.  Six Moments of Infection Prevention in Injection Drug Use: An Educational Toolkit for Clinicians.

Authors:  Leah Harvey; Jacqueline Boudreau; Samantha K Sliwinski; Judith Strymish; Allen L Gifford; Justeen Hyde; Katherine Linsenmeyer; Westyn Branch-Elliman
Journal:  Open Forum Infect Dis       Date:  2022-01-06       Impact factor: 4.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.